These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 15896319

  • 1. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 2. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.
    de Micheli M, Bille J, Schueller C, Sanglard D.
    Mol Microbiol; 2002 Mar 24; 43(5):1197-214. PubMed ID: 11918807
    [Abstract] [Full Text] [Related]

  • 3. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP.
    FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans.
    Manoharlal R, Gaur NA, Panwar SL, Morschhäuser J, Prasad R.
    Antimicrob Agents Chemother; 2008 Apr 15; 52(4):1481-92. PubMed ID: 18268086
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov 15; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 6. Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Shukla S, Yadav V, Mukhopadhyay G, Prasad R.
    Eukaryot Cell; 2011 Oct 15; 10(10):1357-66. PubMed ID: 21856931
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb 15; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 8. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D, Ischer F, Monod M, Bille J.
    Microbiology (Reading); 1997 Feb 15; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [Abstract] [Full Text] [Related]

  • 9. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.
    Karababa M, Coste AT, Rognon B, Bille J, Sanglard D.
    Antimicrob Agents Chemother; 2004 Aug 15; 48(8):3064-79. PubMed ID: 15273122
    [Abstract] [Full Text] [Related]

  • 10. Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2.
    De Deken X, Raymond M.
    Antimicrob Agents Chemother; 2004 Jul 15; 48(7):2700-3. PubMed ID: 15215129
    [Abstract] [Full Text] [Related]

  • 11. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
    Bhattacharya S, Sobel JD, White TC.
    Antimicrob Agents Chemother; 2016 Oct 15; 60(10):5858-66. PubMed ID: 27431223
    [Abstract] [Full Text] [Related]

  • 12. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R.
    J Biol Chem; 2013 Jun 07; 288(23):16775-16787. PubMed ID: 23592791
    [Abstract] [Full Text] [Related]

  • 13. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Manoharlal R, Gorantala J, Sharma M, Sanglard D, Prasad R.
    Microbiology (Reading); 2010 Feb 07; 156(Pt 2):313-326. PubMed ID: 19910410
    [Abstract] [Full Text] [Related]

  • 14. Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans.
    Gaur NA, Puri N, Karnani N, Mukhopadhyay G, Goswami SK, Prasad R.
    FEMS Yeast Res; 2004 Jan 07; 4(4-5):389-99. PubMed ID: 14734019
    [Abstract] [Full Text] [Related]

  • 15. PDR16-mediated azole resistance in Candida albicans.
    Saidane S, Weber S, De Deken X, St-Germain G, Raymond M.
    Mol Microbiol; 2006 Jun 07; 60(6):1546-62. PubMed ID: 16796687
    [Abstract] [Full Text] [Related]

  • 16. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G, Prasad R.
    Yeast; 2004 Feb 07; 21(3):219-39. PubMed ID: 14968428
    [Abstract] [Full Text] [Related]

  • 17. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.
    Coste AT, Karababa M, Ischer F, Bille J, Sanglard D.
    Eukaryot Cell; 2004 Dec 07; 3(6):1639-52. PubMed ID: 15590837
    [Abstract] [Full Text] [Related]

  • 18. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD.
    Antimicrob Agents Chemother; 2008 Nov 07; 52(11):3851-62. PubMed ID: 18710914
    [Abstract] [Full Text] [Related]

  • 19. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 Nov 07; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S, Doluca Dereli M.
    Mikrobiyol Bul; 2014 Apr 07; 48(2):325-34. PubMed ID: 24819270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.